Daniel Afar, based in Redwood City, CA, US, is currently a Vice President, Project Leadership, Oncology Early Development at AbbVie, bringing experience from previous roles at AbbVie, Merck Sharp & Dohme and Facet Biotech (now part of Abbvie Biotherapeutics). Daniel Afar holds a BSc, MSc in Biology, Pharmacology @ McGill University. With a robust skill set that includes Immunology, Oncology, Genomics, Biotechnology, Drug Discovery and more, Daniel Afar contributes valuable insights to the industry. Daniel Afar has 2 emails on RocketReach.